J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 53(7); 2010 > Article
Phi and Chung: Treatment of Epilepsy Associated with Brain Tumors

Abstract

Epilepsy associated with brain tumors (EABT) is a multi-faceted disease that both oncological and epileptological concerns should be taken into consideration. Usually, it is characterized by chronic drug-resistant epilepsy with a low-grade brain tumor in the cerebrum. However, the distinction of typical EABT and simple brain tumors with short-term epilepsy is obscure. We need a working formulation based on the patient? s burden in both oncological and epileptological aspects. The diagnosis of EABT is straightforward, but the treatment should be more complex. Medical treatment with anticonvulsants aloneseems tobe anoutdated remedy for EABT because of the risk of tumor growth and malignant progression in some patients as well as the expected favorable seizure control after surgery. Surgical treatment of EABT has resulted in seizure-free state in about 80% of patients. Complete resection of the tumor is an important prognostic factor in seizure control and probably also in tumor control. Recently, many authors emphasized a lesion-directed surgery aimed at a complete tumor removal in EABT. However, in some patients, especially in patients with dual pathology, electrophysiological studies have to be thoroughly applied. For the treatment of EABT in the temporal lobe, more sophisticated surgical strategy is required. A lesionectomy saving the uninterrupted hippocampus could be applied for selected patients. Further research is strongly needed for better understanding and treatment of EABT and low-grade glioma.

Figure 1.
A diagram depicting the epileptogenesis in the presence of a brain tumor and disease progression. Dual pathology can be attributed to secondary epileptogenesis.
jkma-53-603f1-l.jpg
Figure 2.
MR images of a 36-year-old female with 8-year-history of complex partial seizures. (A)A 2cm-sized tumor (arrow) is observed in right lateral temporal lobe in a T2-weighted image. (B)In a FLAIR image, ipsilateral hippocampus (arrow) is smaller than the counterpart and its signal intensity is increased, which are typical of hippocampal sclerosis. The patient had dual pathology.
jkma-53-603f2-l.jpg
Figure 3.
Preoperative and postoperative T2-weighted MR images of a 22-year-old male with 2-year-history of complex partial seizures. (A)A 1cm-sized tumor (arrow) is observed in left amygdaloid body in a preoperative image. (B)The amygdaloid body and the tumor were completely removed via a transsylvivan approach. The uninvolved hippocampus was preserved. The intact hippocampus (arrow) is observed in a postoperative image.
jkma-53-603f3-l.jpg

REFERENCES

1. Feindel W. Osler vindicated: glioma of the leg center with Jacksonian epilepsy; removal and cure, with a 50-year followup. Historical vignette. J Neurosurg 2009;111:293-300.
pmid
2. Bliss M. Harvey Cushing: A life in surgery. New York: Oxford University Press, Inc. 2005;84-130.

3. Teive HA, Germiniani FM, Cardoso AB, de Paola L, Werneck LC. The uncinated crisis of George Gershwin. Arq Neuropsi-quiatr 2002;60:505-508.
crossref
4. Carp L. George Gershwin-illustrious American composer: his fatal glioblastoma. Am J Surg Pathol 1979;3:473-478.
pmid
5. Silverstein A. The brain tumor of George Gershwin and the legs of Cole Porter. Semin Neurol 1999;19:3-9.
pmid
6. van Breemen MS, Wilms EB, Vecht CJ. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 2007;6:421-430.
crossref pmid
7. Wolf HK, Roos D, Blumcke I, Pietsch T, Wiestler OD. Perilesional neurochemical changes in focal epilepsies. Acta Neuropathol 1996;91:376-384.
crossref pdf
8. Riva M. Brain tumoral epilepsy: a review. Neurol Sci 2005;26:S40-42.
crossref pmid pdf
9. Olafsson E, Ludvigsson P, Gudmundsson G, Hesdorffer D, Kjartansson O, Hauser WA. Incidence of unprovoked seizures and epilepsy in Iceland and assessment of the epilepsy syndrome classification: a prospective study. Lancet Neurol 2005;4:627-634.
crossref
10. Clusmann H, Schramm J, Kral T, Helmstaedter C, Ostertun B, Fimmers R, Haun D, Elger CE. Prognostic factors and outcome after different types of resection for temporal lobe epilepsy. J Neurosurg 2002;97:1131-1141.
crossref
11. Spooner CG, Berkovic SF, Mitchell LA, Wrennall JA, Harvey AS. New-onset temporal lobe epilepsy in children: lesion on MRI predicts poor seizure outcome. Neurology 2006;67:2147-2153.
crossref
12. Luyken C, Blumcke I, Fimmers R, Urbach H, Elger CE, Wiestler OD, Schramm J. The spectrum of longterm epilepsy-associated tumors: longterm seizure and tumor outcome and neurosurgical aspects. Epilepsia 2003;44:822-830.
crossref
13. Phi JH, Chung CK. Brain tumors in the mesial temporal lobe: longterm oncological outcome. Neurosurg Focus 2009;27:E5.
crossref
14. Blumcke I, Wiestler OD. Gangliogliomas: an intriguing tumor entity associated with focal epilepsies. J Neuropathol Exp Neurol 2002;61:575-584.
crossref
15. Nolan MA, Sakuta R, Chuang N, Otsubo H, Rutka JT, Snead OC 3rd, Hawkins CE, Weiss SK. Dysembryoplastic neuroepithelial tumors in childhood: longterm outcome and prognostic features. Neurology 2004;62:2270-2276.
crossref
16. Phi JH, Kim SK, Cho BK, Lee SY, Park SY, Park SJ, Lee SK, Kim KJ, Chung CK. Longterm surgical outcomes of temporal lobe epilepsy associated with low-grade brain tumors. Cancer 2009;115:5771-5779.
crossref
17. Daumas-Duport C, Scheithauer BW, Chodkiewicz JP, Laws ER Jr, Vedrenne C. Dysembryoplastic neuroepithelial tumor: a surgically curable tumor of young patients with intractable partial seizures. Report of thirty-nine cases. Neurosurgery 1988;23:545-556.
pmid
18. Takahashi A, Hong SC, Seo DW, Hong SB, Lee M, Suh YL. Frequent association of cortical dysplasia in dysembryoplastic neuroepithelial tumor treated by epilepsy surgery. Surg Neurol 2005;64:419-427.
crossref
19. Sakuta R, Otsubo H, Nolan MA, Weiss SK, Hawkins C, Rutka JT, Chuang NA, Chuang SH, Snead OC 3rd. Recurrent intractable seizures in children with cortical dysplasia adjacent to dysembryoplastic neuroepithelial tumor. J Child Neurol 2005;20:377-384.
crossref pdf
20. Barkovich AJ, Kuzniecky RI, Jackson GD, Guerrini R, Dobyns WB. A developmental and genetic classification for malformations of cortical development. Neurology 2005;65:1873-1887.
crossref
21. Blumcke I, Lobach M, Wolf HK, Wiestler OD. Evidence for developmental precursor lesions in epilepsy-associated glio-neuronal tumors. Microsc Res Tech 1999;46:53-58.
crossref pmid
22. Bartolomei JC, Christopher S, Vives K, Spencer DD, Piepmeier JM. Low-grade gliomas of chronic epilepsy: a distinct clinical and pathological entity. J Neurooncol 1997;34:79-84.
pmid
23. Piepmeier J, Christopher S, Spencer D, Byrne T, Kim J, Knisel JP, Lacy J, Tsukerman L, Makuch R. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas. Neurosurgery 1996;38:872-878.
pmid
24. Piepmeier JM, Christopher S. Low-grade gliomas: introduction and overview. J Neurooncol 1997;34:1-3.
pmid
25. Blumcke I, Luyken C, Urbach H, Schramm J, Wiestler OD. An isomorphic subtype of longterm epilepsy-associated astrocytomas associated with benign prognosis. Acta Neuropathol 2004;107:381-388.
crossref pdf
26. Schramm J, Luyken C, Urbach H, Fimmers R, Blumcke I. Evidence for a clinically distinct new subtype of grade II astrocytomas in patients with longterm epilepsy. Neurosurgery 2004;55:340-347.
crossref pdf
27. Eriksson SH, Nordborg C, Rydenhag B, Malmgren K. Parenchymal lesions in pharmacoresistant temporal lobe epilepsy: dual and multiple pathology. Acta Neurol Scand 2005;112:151-156.
crossref
28. Salanova V, Markand O, Worth R. Temporal lobe epilepsy: analysis of patients with dual pathology. Acta Neurol Scand 2004;109:126-131.
crossref pdf
29. Stephen LJ, Kwan P, Brodie MJ. Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment? Epilepsia 2001;42:357-362.
crossref
30. Perry A. Pathology of low-grade gliomas: an update of emerging concepts. Neuro Oncol 2003;5:168-178.
crossref
31. Majores M, von Lehe M, Fassunke J, Schramm J, Becker AJ, Simon M. Tumor recurrence and malignant progression of gangliogliomas. Cancer 2008;113:3355-3363.
crossref
32. Luyken C, Blumcke I, Fimmers R, Urbach H, Wiestler OD, Schramm J. Supratentorial gangliogliomas: histopathologic grading and tumor recurrence in 184 patients with a median followup of 8 years. Cancer 2004;101:146-155.
crossref
33. Seeck M. Surgical treatment of tumoral temporal-lobe epilepsy. Lancet Neurol 2003;2:722-723.
crossref
34. Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenite DG, Aaronson NK, Taphoorn MJ, Baaijen H, Vandertop WP, Muller M, Postma TJ, Heimans JJ. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 2003;54:514-520.
crossref
35. Zaatreh MM, Firlik KS, Spencer DD, Spencer SS. Temporal lobe tumoral epilepsy: characteristics and predictors of surgical outcome. Neurology 2003;61:636-641.
crossref
36. Cohen-Gadol AA, Ozduman K, Bronen RA, Kim JH, Spencer DD. Longterm outcome after epilepsy surgery for focal cortical dysplasia. J Neurosurg 2004;101:55-65.
crossref
37. Hader WJ, Mackay M, Otsubo H, Chitoku S, Weiss S, Becker L, Sned OC 3rd, Rutka JT. Cortical dysplastic lesions in children with intractable epilepsy: role of complete resection. J Neurosurg 2004;100:110-117.
crossref
38. Duffau H. Surgery of low-grade gliomas: towards a ?functional neurooncology? Curr Opin Oncol 2009;21:543-549.
crossref
39. Smith JS, Chang EF, Lamborn KR, Chang SM, Prados MD, Cha S, Tihan T, Vandenberg S, McDermott MW, Berger MS. Role of extent of resection in the longterm outcome of low-grade hemispheric gliomas. J Clin Oncol 2008;26:1338-1345.
crossref pmid
40. McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Wuinones-Hinojosa A. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery 2008;63:700-707.
crossref pdf
41. Sanai N, Mirzadeh Z, Berger MS. Functional outcome after language mapping for glioma resection. N Engl J Med 2008;358:18-27.
crossref
42. Lombardi D, Marsh R, de Tribolet N. Low grade glioma in intractable epilepsy: lesionectomy versus epilepsy surgery. Acta Neurochir Suppl 1997;68:70-74.
crossref
43. Jooma R, Yeh HS, Privitera MD, Gartner M. Lesionectomy versus electrophysiologically guided resection for temporal lobe tumors manifesting with complex partial seizures. J Neurosurg 1995;83:231-236.
crossref
44. Sugano H, Shimizu H, Sunaga S. Efficacy of intraoperative electrocorticography for assessing seizure outcomes in intractable epilepsy patients with temporal-lobe-mass lesions. Seizure 2007;16:120-127.
crossref
45. Giulioni M, Galassi E, Zucchelli M, Volpi L. Seizure outcome of lesionectomy in glioneuronal tumors associated with epilepsy in children. J Neurosurg 2005;102:288-293.
crossref
46. Kim SK, Wang KC, Hwang YS, Kim KJ, Cho BK. Intractable epilepsy associated with brain tumors in children: surgical modality and outcome. Childs Nerv Syst 2001;17:445-452.
crossref pdf
47. Minkin K, Klein O, Mancini J, Lena G. Surgical strategies and seizure control in pediatric patients with dysembryoplastic neuroepithelial tumors: a single-institution experience. J Neurosurg Pediatrics 2008;1:206-210.
crossref
48. Chang EF, Potts MB, Keles GE, Lamborn KR, Chang SM, Barbaro NM, Berger MS. Seizure characteristics and control following resection in 332 patients with low-grade gliomas. J Neurosurg 2008;108:227-235.
crossref
49. Cataltepe O, Turanli G, Yalnizoglu D, Topcu M, Akalan N. Surgical management of temporal lobe tumor-related epilepsy in children. J Neurosurg 2005;102:280-287.
crossref


ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next